Outsourcing the Moonshot: Building External Teams When the Playbook Doesn't Exist
By Jeffrey S. Buguliskis, PhD, Deputy Chief Editor, Outsourced Pharma
How do you manage high-risk, breakthrough science through external partners when there is no established playbook to follow? In this episode of The Outsourcing Advisor, Dr. Michael Koeris, Director of DARPA's Biological Technologies Office (BTO), explains how an organization with no internal labs builds and steers external teams to turn ambitious concepts into manufacturable reality. He shares practical lessons on active program management, flexible milestones, integrating CMC and manufacturing early, and funding independent verification to ensure reproducibility, before putting those principles to the test in a rapid-fire "Go, No-Go, or Reframe" segment covering supply chain fragility, academic tech transfer, and scaling without rebuilding the entire stack.
To sign up for the DARPA Biological Technologies Office (BTO) monthly outreach newsletter, send an email to BTO_Outreach@darpa.mil to request inclusion in their distribution list.
You can also browse current program updates, solicitations, and archived editions directly through the DARPA Biological Technologies Office page.